help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

This version published online on May 22, 2007
Journal of Clinical Endocrinology & Metabolism, doi:10.1210/jc.2007-0231
A more recent version of this article appeared on August 1, 2007
This Article
Right arrow Author Manuscript (PDF)
Right arrow All Versions of this Article:
92/8/3189    most recent
Author Manuscript (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sørensen, K
Right arrow Articles by Juul, A
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sørensen, K
Right arrow Articles by Juul, A
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*ESTRADIOL
*TESTOSTERONE
Related Collections
Right arrow Neuroendocrinology and Pituitary
Right arrow Pediatric Endocrinology
Right arrow Female Endocrinology

Submitted on January 31, 2007
Accepted on May 10, 2007

Serum sex hormone binding globulin levels in healthy children and girls with precocious puberty before and during GnRH agonist treatment

K Sørensen*, A M Andersson, N E Skakkebæk, and A Juul

University Department of Growth and Reproduction GR, Rigshospitalet, University of Copenhagen, Denmark

* To whom correspondence should be addressed. E-mail: kaspar.soerensen{at}rh.regionh.dk.

Context: The regulation of SHBG is complex and influenced by sex steroids and insulin. Objective: To describe serum levels and evaluate determinants of SHBG levels in healthy children, and in girls with central precocious puberty (CCP) before and during gonadotropin releasing hormone analogue (GnRHa) treatment. Design: Cross-sectional on healthy subjects, and 2-years longitudinal in girls with CPP. Setting: Tertiary referral centre for paediatric endocrinology. Participants/patients: Nine-hundred and three healthy school children served as healthy subjects. Twenty-five girls with precocious/early puberty. Interventions: Girls with CPP were treated with the long-acting GnRHa Triptorelin. Results: SHBG levels declined with increasing age in both sexes until adulthood. In healthy children, SHBG was significantly negatively correlated with Testosterone (T), Estradiol (E2), Dehydroepiandrosterone Sulphate (DHEAS) and body mass index (BMI) in boys (total model R2 = 0.71), but only with DHEAS and BMI in girls (total model R2 = 0.26). Body fat percentage was significantly negatively correlated with SHBG levels (P < 0.001) in both boys (R2 = 0.18) and girls (R2 = 0.23). Girls with CPP had significantly lower pre-treatment SHBG levels compared to age-matched controls (SHBG-SDS -1.29 [-4.48; 0.01]), which declined even further during GnRHa treatment (-2.75 [-5.9; 0.53]; P < 0.001). Even after adjustment for BMI and pubertal stage girls with CPP had lower SHBG levels (P < 0.001) compared to healthy controls. Conclusions: SHBG levels were strongly dependent on body composition and sex steroid levels in children with normal and precocious puberty. Studies on insulin sensitivity and SHBG in puberty are needed in order to better understand the interaction between body composition and gonadal maturation.


Key words: SHBG • Precocious puberty • Sex steroids • Body composition







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2007 by The Endocrine Society